Compositions pour embolisation percutanée

European patent · EP0291177 · Deleted

Register entry

Publication number
EP0291177
Application number
EP88303395
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 14, 1988
Published
Nov 17, 1988
Granted
Apr 1, 1992
Deleted
Apr 30, 2004
Reason
Annual fee unpaid
IPC classes
A61K 37/54 (1990.01)
A61K 37/547 (1990.01)
Priority
US A 47419 06.05.1987
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 15, 2004

    Deleted, fee unpaid

    Published in +pat+ No 23 in 2004

  2. Dec 13, 2002

    Address changed

    Owner
    Biomatrix, Inc., 65 Railroad Avenue, Ridgefield/NJ, USA → Seagull Merger Corporation, c/o Genzyme Corporation, One Kendall Square, Cambridge/MA 02139, USA

    Published in +pat+ No 23 in 2002

  3. Dec 13, 2002

    Address changed

    Owner
    Seagull Merger Corporation, c/o Genzyme Corporation, One Kendall Square, Cambridge/MA 02139, USA → Genzyme Biosurgery Corporation, One Kendall Square, Cambridge/MA 02139, USA

    Published in +pat+ No 23 in 2002

  4. May 15, 1992

    Granted

    Published in PIDTJ No 9 in 1992

Parties

Inventor

Leshchiner, Adolf

Fairview NJ 07022, US

Larsen, Nancy E.

Southfield NY 10975, US

Balazs, Endre A.

Fort Lee NJ 07024, US

Hilal, Sadek K.

Englewood Cliffs NJ 07632, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.